ZA972203B - New 2-(3H)-oxazolone derivatives. - Google Patents

New 2-(3H)-oxazolone derivatives.

Info

Publication number
ZA972203B
ZA972203B ZA9702203A ZA972203A ZA972203B ZA 972203 B ZA972203 B ZA 972203B ZA 9702203 A ZA9702203 A ZA 9702203A ZA 972203 A ZA972203 A ZA 972203A ZA 972203 B ZA972203 B ZA 972203B
Authority
ZA
South Africa
Prior art keywords
new
oxazolone derivatives
oxazolone
derivatives
Prior art date
Application number
ZA9702203A
Other languages
English (en)
Inventor
Carles Puig Duran
Ferran Pujol Noguera
Dolors Fernandez Forner
Original Assignee
Grupo Farmaceutico Almirall S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8294266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA972203(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grupo Farmaceutico Almirall S filed Critical Grupo Farmaceutico Almirall S
Publication of ZA972203B publication Critical patent/ZA972203B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9702203A 1996-03-21 1997-03-13 New 2-(3H)-oxazolone derivatives. ZA972203B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009600685A ES2125161B1 (es) 1996-03-21 1996-03-21 Nuevos derivados de 2-(3h)-oxazolona.

Publications (1)

Publication Number Publication Date
ZA972203B true ZA972203B (en) 1997-09-25

Family

ID=8294266

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702203A ZA972203B (en) 1996-03-21 1997-03-13 New 2-(3H)-oxazolone derivatives.

Country Status (30)

Country Link
US (1) US6869968B1 (ja)
EP (1) EP0888316B1 (ja)
JP (1) JP3810091B2 (ja)
KR (1) KR100496395B1 (ja)
CN (1) CN1110488C (ja)
AR (1) AR006340A1 (ja)
AT (1) ATE197294T1 (ja)
AU (1) AU713811B2 (ja)
BR (1) BR9708141A (ja)
CA (1) CA2249420A1 (ja)
CO (1) CO4780046A1 (ja)
CZ (1) CZ294963B6 (ja)
DE (1) DE69703437T2 (ja)
DK (1) DK0888316T3 (ja)
ES (2) ES2125161B1 (ja)
GR (1) GR3035096T3 (ja)
HK (1) HK1015371A1 (ja)
ID (1) ID16778A (ja)
IL (1) IL126206A (ja)
NO (1) NO311761B1 (ja)
NZ (1) NZ331901A (ja)
PE (1) PE42898A1 (ja)
PL (1) PL188722B1 (ja)
PT (1) PT888316E (ja)
RU (1) RU2194043C2 (ja)
TW (1) TW426674B (ja)
UA (1) UA52645C2 (ja)
UY (1) UY24499A1 (ja)
WO (1) WO1997034882A1 (ja)
ZA (1) ZA972203B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
ES2131015B1 (es) * 1997-09-12 2000-03-01 Almirall Prodesfarma Sa Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
ES2168895A1 (es) * 1999-03-26 2002-06-16 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
ES2154561B1 (es) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
IL150368A0 (en) 1999-12-23 2002-12-01 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2004002420A2 (en) 2002-06-28 2004-01-08 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
ES2215474B1 (es) 2002-12-24 2005-12-16 J. URIACH & CIA S.A. Nuevos derivados de fosforamida.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
PL1534305T3 (pl) 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
CN1309717C (zh) * 2003-06-03 2007-04-11 李小虎 4－芳基－5h－噻吩－2－酮衍生物、其制法和用途
EP2114461A2 (en) * 2007-01-19 2009-11-11 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866182A (en) 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
DE4435547A1 (de) 1994-10-05 1996-04-11 Bayer Ag Sulfonylaminocarbonyltriazolinone mit über Sauerstoff und Schwefel gebundenen Substituenten
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique

Also Published As

Publication number Publication date
DE69703437T2 (de) 2001-03-08
AR006340A1 (es) 1999-08-25
US6869968B1 (en) 2005-03-22
KR20000064727A (ko) 2000-11-06
DE69703437D1 (de) 2000-12-07
EP0888316B1 (en) 2000-11-02
PL328915A1 (en) 1999-03-01
CN1110488C (zh) 2003-06-04
GR3035096T3 (en) 2001-03-30
CZ294963B6 (cs) 2005-04-13
UA52645C2 (uk) 2003-01-15
CZ297998A3 (cs) 1999-02-17
ID16778A (id) 1997-11-13
ES2125161B1 (es) 1999-11-16
AU713811B2 (en) 1999-12-09
ATE197294T1 (de) 2000-11-15
TW426674B (en) 2001-03-21
PL188722B1 (pl) 2005-04-29
RU2194043C2 (ru) 2002-12-10
PE42898A1 (es) 1998-08-12
NO311761B1 (no) 2002-01-21
JP2000506876A (ja) 2000-06-06
AU2289397A (en) 1997-10-10
NO984325L (no) 1998-11-23
HK1015371A1 (en) 1999-10-15
CN1218459A (zh) 1999-06-02
KR100496395B1 (ko) 2005-09-27
MX9701944A (es) 1998-06-30
IL126206A0 (en) 1999-05-09
UY24499A1 (es) 1997-04-02
JP3810091B2 (ja) 2006-08-16
NO984325D0 (no) 1998-09-17
IL126206A (en) 2001-06-14
EP0888316A1 (en) 1999-01-07
CO4780046A1 (es) 1999-05-26
NZ331901A (en) 1999-10-28
DK0888316T3 (da) 2000-11-27
WO1997034882A1 (en) 1997-09-25
PT888316E (pt) 2001-02-28
ES2151254T3 (es) 2000-12-16
ES2125161A1 (es) 1999-02-16
CA2249420A1 (en) 1997-09-25
BR9708141A (pt) 1999-07-27

Similar Documents

Publication Publication Date Title
ZA98362B (en) 3-heterocyclyl-substituted benzoyl derivatives.
ZA97927B (en) New substituted oxazolidinones.
EG25227A (en) Heterocyclic compounds.
ZA97912B (en) Heterocyclic compounds.
HK1018216A1 (en) New 19-nor-pregnene derivatives.
AP9901572A0 (en) 2-(Purin-9 yl)-tetrahydrofur-n-3,4-diol derivatives
ZA965935B (en) Heterocyclic compounds.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA978045B (en) New benzamidine derivatives.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA972203B (en) New 2-(3H)-oxazolone derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA979617B (en) Novel heterocyclic compounds.
HUP9900400A3 (en) Isoxazole derivatives
ZA967741B (en) Diarylalkenylamine derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA977036B (en) Substituted oxadiazine derivatives.
ZA988303B (en) New 2-(3H)-oxazolone derivatives
ZA9810039B (en) Azoline derivatives
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.